Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Houston TX, Nashville TN, Atlanta GA, Tampa FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase1, Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Houston TX, Dallas TX, Fort Worth TX, Jeffersonville IN,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase3, Recruiting

Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients

for
Multiple Endocrine Neoplasia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03048266

Recruiting

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

for
Prostate Cancer
Location: Houston TX, Ann Arbor MI, London, Toronto, Ottawa,
Sponsor: University of British Columbia

Sex: Male

Age: 18+

Code: NCT04812366

Phase2, Recruiting

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

for
Systemic Lupus Erythematosus
Location: Katy TX, Euless TX, Jackson MS, Amarillo TX, Memphis TN,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT07409181

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

for
Hematopoietic and Lymphoid Cell Neoplasm, Immunocompromised
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03425526

Phase1, Recruiting

Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations

for
Targeted Therapy, IDH1-Mutated Malignancies, Mutations
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07032727

Phase2, Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Houston TX, Birmingham AL, Toronto, Hackensack NJ,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06988488

Phase1, Phase2, Recruiting

Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

for
Neuromuscular Block, Residual
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT07084363

Recruiting

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

for
Fibrosis Syndrome, Lymphedema, Head &Amp; Neck Cancer, Fibrosis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 0+

Code: NCT06912763

Phase2, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Bellaire TX, Katy TX, The Woodlands TX, Austin TX,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

for
Bone Sarcomas, Financial Toxicity
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT07215611

Recruiting

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma

for
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06448026

Phase2, Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

for
Non-obstructive Hypertrophic Cardiomyopathy
Location: Houston TX, Plano TX, St Louis MO, Charlotte NC,
Sponsor: Imbria Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07023614

Phase2, Recruiting

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Houston TX, Oklahoma City OK, Olathe KS,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase2, Recruiting

Open-label Extension Study in Participants With Early Alzheimer's Disease

for
Alzheimer's Disease
Location: Houston TX, Oklahoma City OK, Maitland FL, Matthews NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 50 - 70+

Code: NCT07105709

Phase2, Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

for
Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma,
Location: Houston TX, Austin TX, San Antonio TX, Nashville TN,
Sponsor: Aulos Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05267626

Phase1, Phase2, Recruiting

A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

for
Soft Tissue Sarcomas
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 1 - 30

Code: NCT07444619

Phase1, Recruiting

Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients

for
Advanced Cancers
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT02160366

Recruiting

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

for
Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer,
Location: Houston TX, San Antonio TX, Irving TX, Nashville TN,
Sponsor: Incendia Therapeutics

Sex: All

Age: 18+

Code: NCT05753722

Phase1, Recruiting